GSK PLC (NYSE:GSK)
$ 34.08 -0.04 (-0.12%) Market Cap: 69.61 Bil Enterprise Value: 84.95 Bil PE Ratio: 21.96 PB Ratio: 3.90 GF Score: 71/100

Q3 2021 GlaxoSmithKline PLC Earnings Call Transcript

Oct 27, 2021 / 01:00PM GMT
Release Date Price: $41.56 (+0.60%)
Operator

Good afternoon, everyone, and welcome to the analyst call on the GSK Third Quarter 2021 Results. I will now hand you over to Nick Stone, Head of Investor Relations, who will introduce today's session.

Nick Stone

Thank you, operator. Good morning and good afternoon. As you've just heard, I am Nick Stone, Head of Investor Relations at GSK. It's my pleasure to welcome you to our third quarter 2020 conference call and webcast for investors and analysts. The presentation was posted to gsk.com and was also sent to our distribution list a little bit earlier today.

Please turn to Slide 2. This is the usual safe harbor statement, and we'll be making comments on performance using constant exchange rates, or CER.

Please turn to Slide 3. This is today's agenda where we'll plan to cover all aspects of our results. The presentation will last approximately 25 minutes in order to maximize the opportunity for questions. (Operator Instructions)

Our speakers today are Emma Walmsley, Luke Miels, Deborah Waterhouse, Brian McNamara and Iain MacKay. The Q&A

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot